The initial success of Sildenafil undeniably reshaped the pharmaceutical landscape, but placing funds in companies strongly reliant on off-patent versions presents a challenging picture. Despite early profits were https://knockoff436258.blogoscience.com/48589006/sildenafil-and-pharma-a-hazardous-investment